Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)

Cyclerion Therapeutics' Assets Average history runs 7 years deep, the most recent figure standing at $10.2 million for Q4 2025.

• In Q4 2025, Assets Average rose 10.43% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $10.2 million (up 10.43% YoY), while the FY2025 annual figure was $9.8 million, down 14.77% from the prior year.
• Assets Average was $10.2 million for Q4 2025 at Cyclerion Therapeutics, up from $9.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $107.7 million in Q1 2021 to a low of $9.2 million in Q4 2024.
• Historically, Assets Average has averaged $30.5 million across 5 years, with a median of $13.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average sank 73.63% in 2023, then increased 10.43% in 2025.
• A 5-year view of Assets Average shows it stood at $63.5 million in 2021, then slumped by 66.06% to $21.6 million in 2022, then sank by 33.72% to $14.3 million in 2023, then plunged by 35.38% to $9.2 million in 2024, then rose by 10.43% to $10.2 million in 2025.
• The last three Assets Average figures came in at $10.2 million (Q4 2025), $9.9 million (Q3 2025), and $9.6 million (Q2 2025), per Business Quant data.